Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Angiotensin receptor blockers were associated with worse outcomes in patients with celiac disease ...

In a recent study published in the BMJ, researchers conducted a phase three, multicenter, randomized controlled trial to evaluate the effect of using angiotensin receptor blockers that disrupt the ...

CHICAGO — Patients with reduced left ventricular ejection fraction who were discharged after being hospitalized for acute MI and took ACE inhibitors or angiotensin receptor blockers had decreased risk ...

Angiotensin receptor blockers exhibited potential neuroprotective properties for reducing Parkinson disease (PD) risk in patients with newly diagnosed hypertension. A statistically significant ...

Angiotensin II, the principal effector peptide of the renin-angiotensin-aldosterone system (RAAS), has potent vasoconstrictive and other effects that can lead to cardiac and renal complications.

Rotterdam, the Netherlands - Investigators assessing the antiproteinuric effects of the angiotensin 2 receptor blocker (ARB) losartan (Cozaar ®, Merck) have found the drug reduces urinary albumin ...

Emerging concerns that common antihypertensive treatment approaches with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) – jointly known as ...

In the search for treatments for COVID-19, many researchers are focusing their attention on a specific protein that allows the virus to infect human cells. Called the angiotensin-converting enzyme 2, ...

Despite long-term and adequate ACE inhibition, angiotensin II concentrations return to pretreatment levels or higher. [14,15] Several ACE-independent enzymes have been found to produce angiotensin II.

First-line durvalumab with arterial chemotherapy in major portal invaded hepatocellular carcinoma: The phase 2 DurHope study with biomolecular analyses. Comparative diagnostic accuracy and tumor ...